Description
PURCHASE OF REAGENTS/GELS FOR SERUM/URINE PROTEIN ELECTROPHORESIS AND SERUM/URINE IMMUNOFIXATION TO INCLUDE THE LEASE OF THE EQUIPMENT TO PERFORM TESTING AND THE DENSITOMETER AND SOFTWARE TO COMPLETE THE PATIENT REPORTABLE RESULTS.
Modification chain · 6 transactions
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2018-04-11+$38,418= $38,418
- Mod P000012019-02-28+$0= $38,418
- Mod P000022020-02-28+$0= $38,418
- Mod P000032021-02-25+$38,790= $77,208
- Mod P000042021-06-17-$6,750= $70,458
- Mod P000062022-10-25-$303= $70,155
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2018-04-11 | +$38,418 | $38,418 | PURCHASE OF REAGENTS/GELS FOR SERUM/URINE PROTEIN ELECTROPHORESIS AND SERUM/URINE IMMUNOFIXATION TO INCLUDE TH… |
| Mod P00001· OTHER ADMINISTRATIVE ACTION | 2019-02-28 | +$0 | $38,418 | PURCHASE OF REAGENTS/GELS FOR SERUM/URINE PROTEIN ELECTROPHORESIS AND SERUM/URINE IMMUNOFIXATION TO INCLUDE TH… |
| Mod P00002· OTHER ADMINISTRATIVE ACTION | 2020-02-28 | +$0 | $38,418 | PURCHASE OF REAGENTS/GELS FOR SERUM/URINE PROTEIN ELECTROPHORESIS AND SERUM/URINE IMMUNOFIXATION TO INCLUDE TH… |
| Mod P00003· EXERCISE AN OPTION | 2021-02-25 | +$38,790 | $77,208 | PURCHASE OF REAGENTS/GELS FOR SERUM/URINE PROTEIN ELECTROPHORESIS AND SERUM/URINE IMMUNOFIXATION TO INCLUDE TH… |
| Mod P00004· FUNDING ONLY ACTION | 2021-06-17 | −$6,750 | $70,458 | PURCHASE OF REAGENTS/GELS FOR SERUM/URINE PROTEIN ELECTROPHORESIS AND SERUM/URINE IMMUNOFIXATION TO INCLUDE TH… |
| Mod P00006· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE | 2022-10-25 | −$303 | $70,155 | PURCHASE OF REAGENTS/GELS FOR SERUM/URINE PROTEIN ELECTROPHORESIS AND SERUM/URINE IMMUNOFIXATION TO INCLUDE TH… |
Related awards · 11
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI P31QQPK7RDA5)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| 36C26026N0385 | 260-NETWORK CONTRACT OFFICE 20 (36C260) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $167,781 | FY2026 |
| 36C24426P0411 | 244-NETWORK CONTRACT OFFICE 4 (36C244) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $56,685 | FY2026 |
| 36C25026N0494 | 250-NETWORK CONTRACT OFFICE 10 (36C250) · 6640 · LABORATORY EQUIPMENT AND SUPPLIES | $71,078 | FY2026 |
| 36C25926N0302 | NETWORK CONTRACT OFFICE 19 (36C259) · 6640 · LABORATORY EQUIPMENT AND SUPPLIES | $48,920 | FY2026 |
| 36C24426P0173 | 244-NETWORK CONTRACT OFFICE 4 (36C244) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $27,580 | FY2026 |
| 36C26026A0009 | 260-NETWORK CONTRACT OFFICE 20 (36C260) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $0 | FY2026 |
Other recipients under 6550 from 244-NETWORK CONTRACT OFFICE 4 (36C244) (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| 36C24426N1004 | ABBOTT LABORATORIES INC. | 244-NETWORK CONTRACT OFFICE 4 (36C244) | $187,594 | FY2026 |
| 36C24426N1002 | ABBOTT LABORATORIES INC. | 244-NETWORK CONTRACT OFFICE 4 (36C244) | $607,544 | FY2026 |
| 36C24426N1001 | ABBOTT LABORATORIES INC. | 244-NETWORK CONTRACT OFFICE 4 (36C244) | $431,969 | FY2026 |
| 36C24426N1003 | ABBOTT LABORATORIES INC. | 244-NETWORK CONTRACT OFFICE 4 (36C244) | $267,954 | FY2026 |
| 36C24426N1005 | ABBOTT LABORATORIES INC. | 244-NETWORK CONTRACT OFFICE 4 (36C244) | $395,322 | FY2026 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_36C24418C0141_3600_-NONE-_-NONE- · retrieved 2026-09-26.